Proteostasis

Proteostasis is the cell's management of its own protein population: folding what is newly made, refolding what has come undone, and disposing of what cannot be saved. It is a budget rather than a mechanism — chaperones, the ubiquitin–proteasome system and the autophagy–lysosome pathway all draw on it — and a neuron is unusually exposed to it, being post-mitotic and unable to dilute a bad protein load by dividing.

In this corpus proteostasis matters less as a pathway than as a piece of timing evidence. Two submissions reach it from opposite ends: one by asking the data when things go wrong, the other by naming a specific molecule that overloads it.

The timing claim

Shokhirev (submission 113) applied machine learning and multi-omics to 4,089 samples and extracted nine hallmarks impaired in Alzheimer's disease: cell death, cellular senescence, energy metabolism, genomic integrity, glia, immune system, metal ion homeostasis, proteostasis, and synaptic function.

The load-bearing result is not the list but its ordering. Stratifying by age, proteostasis and energy metabolism emerge as the earliest drivers in patients under 75, while immune activation and cell death appear later. That is a data-derived temporal hierarchy rather than an assumed one, and the corpus treats it as independent support for a sequenced account of the disease — proteostatic and bioenergetic failure first, inflammation second.

This is one of the few places where the corpus's phase ordering is corroborated by something other than the corpus's own reasoning, which is why it is cited well beyond its own page.

The overload claim

Cox (submission 120) supplies a concrete way to break the budget. The proposal is that the sporadic character of Alzheimer's is explained by chronic environmental exposure to BMAA (β-N-methylamino-L-alanine), a cyanobacterial neurotoxin misincorporated into proteins in place of L-serine. A protein built around the wrong residue misfolds; enough of them overload the proteostatic network and, on this account, drive it into autophagic collapse.

The proposal carries an unusually direct therapeutic corollary: L-serine supplementation should competitively inhibit the misincorporation. That makes it falsifiable in a way most exposure hypotheses are not.

Why the corpus keeps it upstream

Both submissions load the Endosomal Nexus node (6 each), which is where proteostatic failure becomes lysosomal failure. The corpus's foundational Phase II mechanism — PANTHOS neurons engorged with undigested autophagic vacuoles because their lysosomes cannot acidify — is proteostatic collapse observed at the level of morphology. Proteostasis is therefore not a parallel hallmark but the budget whose exhaustion the lysosomal argument describes.

Read alongside Energy Metabolism, with which Shokhirev pairs it in the earliest stratum, the claim is that the first thing to fail in Alzheimer's is not a structure but an affordability: the neuron can no longer pay to keep its proteins correct.

Advanced by

Submission 113, Maxim Shokhirev — nine hallmarks with a temporal hierarchy, from multi-omics of 4,089 samples. Submission 120, Paul Cox — BMAA misincorporation, proteostatic overload, and L-serine competition.

Related

Protein Misfolding · Autophagic Flux · Lysosomal Dysfunction · Energy Metabolism · Tau Pathology · Endosomal Nexus